Deciphera Pharmaceuticals, Inc. Forms 3, 4 and 5: Warrants

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 4 rows, 4 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

2024-04-22: Reporting owner Brightstar Associates LLC; Form 4; Security Warrants (right to buy); Transaction X Exercise of in-the-money or at-the-money derivative security.
2024-02-07: Reporting owner Brightstar Associates LLC; Form 4; Security Warrants (right to buy); Transaction X Exercise of in-the-money or at-the-money derivative security.
2023-02-28: Reporting owner Brightstar Associates LLC; Form 4; Security Warrants (right to buy); Transaction X Exercise of in-the-money or at-the-money derivative security.
2022-04-29: Reporting owner Brightstar Associates LLC; Form 4; Security Warrants (right to buy); Transaction P Open market or private purchase of non-derivative or derivative security.

Purchase (P)All rows

Transaction date	Reporting owner	Form	Security	Transaction	Shares	Price	Filing
2024-04-22	Brightstar Associates LLC 10% Owner	4	Warrants (right to buy) Derivative · Direct	X Exercise of in-the-money or at-the-money derivative security	−48,136 0 owned after	$0.01 exercise price	2024-04-24
2024-02-07	Brightstar Associates LLC 10% Owner	4	Warrants (right to buy) Derivative · Direct	X Exercise of in-the-money or at-the-money derivative security	−914,001 48,136 owned after	$0.01 exercise price	2024-02-09
2023-02-28	Brightstar Associates LLC 10% Owner	4	Warrants (right to buy) Derivative · Direct	X Exercise of in-the-money or at-the-money derivative security	−2,427,693 962,137 owned after	$0.01 exercise price	2023-03-01
2022-04-29	Brightstar Associates LLC 10% Owner	4	Warrants (right to buy) Derivative · Direct	P Open market or private purchase of non-derivative or derivative security	+3,389,830 3,389,830 owned after	$9.99	2022-04-29